BRPI9910445B8 - preparação farmacêutica na forma de comprimido, bem como seu processo de produção - Google Patents

preparação farmacêutica na forma de comprimido, bem como seu processo de produção

Info

Publication number
BRPI9910445B8
BRPI9910445B8 BRPI9910445A BR9910445A BRPI9910445B8 BR PI9910445 B8 BRPI9910445 B8 BR PI9910445B8 BR PI9910445 A BRPI9910445 A BR PI9910445A BR 9910445 A BR9910445 A BR 9910445A BR PI9910445 B8 BRPI9910445 B8 BR PI9910445B8
Authority
BR
Brazil
Prior art keywords
pharmaceutical preparation
well
production process
tablet form
preparation
Prior art date
Application number
BRPI9910445A
Other languages
English (en)
Other versions
BRPI9910445B1 (pt
BR9910445A (pt
Inventor
Nischwitz Marion
Schreder Sven
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR9910445A publication Critical patent/BR9910445A/pt
Publication of BRPI9910445B1 publication Critical patent/BRPI9910445B1/pt
Publication of BRPI9910445B8 publication Critical patent/BRPI9910445B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

patente de invenção: <b>''preparação farmacêutica''<d>. a invenção refere-se a uma preparação farmacêutica que compreende levotiroxina sódica, gelatina e cargas, preparação esta que é livre de resíduos de solvente orgânico, e a processos para sua produção.
BRPI9910445A 1998-05-15 1999-05-05 preparação farmacêutica na forma de comprimido, bem como seu processo de produção BRPI9910445B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19821625A DE19821625C1 (de) 1998-05-15 1998-05-15 Pharmazeutische Zubereitung
PCT/EP1999/003087 WO1999059551A1 (de) 1998-05-15 1999-05-05 Levothyroxin natrium enthaltende pharmazeutische zubereitung

Publications (3)

Publication Number Publication Date
BR9910445A BR9910445A (pt) 2001-01-02
BRPI9910445B1 BRPI9910445B1 (pt) 2017-05-09
BRPI9910445B8 true BRPI9910445B8 (pt) 2021-05-25

Family

ID=7867752

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9910445A BRPI9910445B8 (pt) 1998-05-15 1999-05-05 preparação farmacêutica na forma de comprimido, bem como seu processo de produção

Country Status (25)

Country Link
US (2) US6646007B1 (pt)
EP (1) EP1077681B1 (pt)
JP (1) JP4709379B2 (pt)
CN (1) CN1145479C (pt)
AR (1) AR018607A1 (pt)
AT (1) ATE225651T1 (pt)
AU (1) AU742382B2 (pt)
BR (1) BRPI9910445B8 (pt)
CA (1) CA2333193A1 (pt)
CZ (1) CZ300908B6 (pt)
DE (2) DE19821625C1 (pt)
DK (1) DK1077681T3 (pt)
ES (1) ES2184452T3 (pt)
HU (1) HU228958B1 (pt)
ID (1) ID27281A (pt)
MY (1) MY120570A (pt)
NO (1) NO331655B1 (pt)
PL (1) PL194088B1 (pt)
PT (1) PT1077681E (pt)
RU (1) RU2225711C2 (pt)
SK (1) SK284155B6 (pt)
TW (1) TW561058B (pt)
UA (1) UA73474C2 (pt)
WO (1) WO1999059551A1 (pt)
ZA (1) ZA200007509B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
ITMI20011401A1 (it) * 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei
US20030099699A1 (en) * 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
US20040152783A1 (en) * 2002-11-05 2004-08-05 Olon Lawrence Peter Controlled absorption of admixed thyroid hormone formulations
ITMI20110713A1 (it) 2011-04-29 2012-10-30 Bracco Imaging Spa Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
GB0316206D0 (en) * 2003-07-10 2003-08-13 Glaxo Group Ltd Pharmaceutical formulation
WO2006054120A1 (en) 2004-11-18 2006-05-26 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Dry powder comprising levothyroxine sodium administered via inhalator
GB0525461D0 (en) * 2005-12-15 2006-01-25 Archimedes Dev Ltd Pharmaceutical compositions
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
WO2014029464A1 (en) * 2012-08-20 2014-02-27 Merck Patent Gmbh Solid pharmaceutical preparation containing levothyroxine
EP2932963A1 (en) 2014-04-16 2015-10-21 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Stable pharmaceutical dosage forms comprising Levothyroxine sodium
US9682045B2 (en) 2014-11-21 2017-06-20 Cadila Healthcare Limited Stable pharmaceutical compositions of thyroid hormone drug
WO2018069805A2 (en) 2016-10-10 2018-04-19 Ftf Pharma Private Limited Method for preparation of liquid oral composition of l-thyroxin
CN109010295A (zh) * 2018-08-29 2018-12-18 北京兴源联合医药科技有限公司 一种左甲状腺素钠冻干口腔崩解片
CN115737576B (zh) * 2022-11-14 2024-05-07 山东创新药物研发有限公司 一种左甲状腺素钠片剂及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6191M (pt) * 1966-02-18 1968-07-22
US3808332A (en) * 1969-01-27 1974-04-30 Armour Pharma Pharmaceutical compositions containing the reaction product of a tertiary phosphine with thyroxine
US3621098A (en) 1969-03-17 1971-11-16 Geigy Chem Corp HYPOTENSIVE METHODS AND COMPOSITIONS UTILIZING HEXAHYDROBENZO{8 b{9 {0 QUINOLIZINES
US3621096A (en) * 1969-04-03 1971-11-16 Univ North Carolina Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone
DE2126533A1 (de) * 1971-05-28 1972-12-14 Merck Patent Gmbh, 6100 Darmstadt Verfahren zur Herstellung pharma zeutischer Zubereitungen
HUT67319A (en) * 1991-08-30 1995-03-28 Life Medical Sciences Inc Compositions for treating wounds
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
AU675557B2 (en) * 1993-06-14 1997-02-06 Janssen Pharmaceutica N.V. Extended release, film-coated tablet of astemizole and pseudoephedrine
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5738875A (en) * 1994-10-28 1998-04-14 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms
SE9500897D0 (sv) * 1995-03-14 1995-03-14 Astra Ab The pharmacological use of certain cystine derivatives
CN1126589A (zh) 1995-06-09 1996-07-17 中国科学院成都有机化学研究所 一种激素缓释微囊注射剂及其制备方法
DE19541128C2 (de) * 1995-10-27 1997-11-27 Henning Berlin Gmbh & Co Stabilisierte schilddrüsenhormonhaltige Arzneimittel
WO1997017951A1 (en) * 1995-11-14 1997-05-22 Knoll Pharmaceutical Company Stabilized thyroid hormone preparations and methods of making same
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine
US20010039335A1 (en) * 1997-04-10 2001-11-08 Kenneth Jacobs Secreted proteins and polynucleotides encoding them
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
DE19830246A1 (de) * 1998-07-07 2000-01-13 Merck Patent Gmbh Pharmazeutische Zubereitung

Also Published As

Publication number Publication date
PL194088B1 (pl) 2007-04-30
US8008349B2 (en) 2011-08-30
EP1077681B1 (de) 2002-10-09
WO1999059551A1 (de) 1999-11-25
BRPI9910445B1 (pt) 2017-05-09
EP1077681A1 (de) 2001-02-28
ATE225651T1 (de) 2002-10-15
HUP0102125A3 (en) 2001-12-28
NO20005758L (no) 2000-11-14
DE59903028D1 (de) 2002-11-14
HUP0102125A2 (hu) 2001-11-28
SK284155B6 (sk) 2004-10-05
DE19821625C1 (de) 2000-01-05
MY120570A (en) 2005-11-30
AR018607A1 (es) 2001-11-28
CN1301148A (zh) 2001-06-27
US6646007B1 (en) 2003-11-11
CA2333193A1 (en) 1999-11-25
AU742382B2 (en) 2002-01-03
CZ300908B6 (cs) 2009-09-09
CZ20004201A3 (cs) 2001-03-14
PL346395A1 (en) 2002-02-11
NO20005758D0 (no) 2000-11-14
AU3932199A (en) 1999-12-06
ZA200007509B (en) 2002-06-14
DK1077681T3 (da) 2002-12-30
PT1077681E (pt) 2003-02-28
RU2225711C2 (ru) 2004-03-20
JP4709379B2 (ja) 2011-06-22
NO331655B1 (no) 2012-02-13
CN1145479C (zh) 2004-04-14
SK16892000A3 (sk) 2001-04-09
BR9910445A (pt) 2001-01-02
UA73474C2 (uk) 2005-08-15
JP2002515421A (ja) 2002-05-28
ES2184452T3 (es) 2003-04-01
ID27281A (id) 2001-03-22
HU228958B1 (en) 2013-07-29
TW561058B (en) 2003-11-11
US20040063611A1 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
BRPI9910445B8 (pt) preparação farmacêutica na forma de comprimido, bem como seu processo de produção
PT1414816E (pt) Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos
BRPI0516842A (pt) compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por lxr alfa e/ou lxr beta agonistas e uso desses compostos
AR017205A1 (es) ANILIDAS MIMÉTICAS DE ÁCIDO RETINOICO, PROCESOS PARA PREPARAR DICHOS COMPUESTOS, COMPOSICIONES FARMACÉUTICAS QUE LOS COMPRENDEN, UN PROCESO PARA PREPARAR DICHAS COMPOSICIONES Y EL USO DE DICHOS COMPUESTOS EN LA ELABORACIoN DE MEDICAMENTOS.
BR9903984B1 (pt) processo para a produção de uma composição aquosa que contém um peptìdeo farmaceuticamente efetivo.
BR0307294A (pt) ésteres de ácido fluorenocarboxìlico, processo para sua preparação bem como seu uso como medicamento
PT1098874E (pt) Benzociclo-heptenos processo para a sua sintese preparacoes farmaceuticas contendo estes compostos assim como sua utilizacao para a fabricacao de medicamentos
BR0015147A (pt) Ciclopropanos como cgrp-antagonistas, medicamentos contendo os ditos compostos e processo para a produção dos mesmos
BRPI0415209A (pt) derivados de tetraidronaftaleno, processo para a produção deles e seu emprego como agentes antiinflamatórios
BRPI0416534A (pt) composições multiparticuladas com estabilidade melhorada
BRPI0408920A (pt) difenilazetidinona com propriedades fisiológicas aperfeiçoadas, processo para a sua preparação, medicamentos contendo esses compostos e sua aplicação
BRPI0519620A2 (pt) compostos, processo para a sua manufatura, composiÇÕes farmacÊuticas que os compreendem, mÉtodo para o tratamento terapÊutico e/ou profilÁtico de enfermidades que sço moduladas por agonistas alfa-lxr e/ou beta-lxr e utilizaÇço desses compostos
BR0013316A (pt) Derivados substituìdos de 2-dialquilaminoalquilbifenila, seu processo de fabricação e seu uso.
BR9604801A (pt) Processo para a produção e purificação de esteres cìclicos
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
BR0311347A (pt) Alcanóis bis-aromáticos
BR0307461A (pt) Derivados de quinazolinona e seu uso como agonistas de cb
BR0008682A (pt) 3-amino-3-arilpropan-1-ol, processo para sua produção, seu uso e medicamento
ATE282607T1 (de) Tryptase-inhibitoren
BR0013175A (pt) Derivados de vitamina d com sub-estruturas cìclicas na cadeias laterais, processos e produtos intermediários para a sua preparação e a utilização para a preparação de medicamentos
BR9907025A (pt) Polissacarìdeos sintéticos, processo para sua preparação e composições farmacêuticas que contêm os mesmos
BR9911884A (pt) Preparação farmacêutica
BR9808009A (pt) Processo para a produção de um produto alimentìcio congelado, e, produto alimentìcio congelado.
BRPI0409060A (pt) processo para produção de cianeto de sódio
BR9914907A (pt) Cápsula mineral, processo para sua preparação, e, utilização das cápsulas

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 9/20, A61K 31/195, A61K 31/198, A61K 47/26, A61K 47/36, A61K 47/38, A61K 47/42, A61P 5/14

Ipc: A61K 9/20 (2009.01), A61K 31/195 (2009.01), A61K 3

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO DE PATENTE, UMA VEZ QUE A MATERIA PLEITEADA NAO APRESENTA NOVIDADE ( ART. 8O E 11 DA LPI ); A MATERIA PLEITEADA NAO APRESENTA ATIVIDADE INVENTIVA ( 8O E 13 DA LPI ); E AS REIVINDICACOES NAO DEFINEM, DE MODO CLARO E PRECISO, A MATERIA OBJETO DE PROTECAO ( ART. 25 DA LPI )

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/05/1999 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 05/05/2019